Moral risk in marketised medicine

[thumbnail of Open Access]
Preview
Text (Open Access)
- Published Version
· Available under License Creative Commons Attribution.
[thumbnail of health.pdf]
Text
- Accepted Version
· Restricted to Repository staff only
· The Copyright of this document has not been checked yet. This may affect its availability.

Please see our End User Agreement.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Elson, L. ORCID: https://orcid.org/0000-0002-3013-8030 (2025) Moral risk in marketised medicine. Ratio. ISSN 1467-9329 doi: 10.1111/rati.70003

Abstract/Summary

We hope that doctors will recommend and provide the most appropriate investigations and treatments. I argue that some ways of structuring medical provision—mostly, those involving markets—impose a risk of overprovision. This is bad financially, medically, and epistemically, and as such is morally bad, and we should be extremely cautious about damaging trust in doctors. Thus “who cares if the doctor works for a private company so long as treatment is free?” defences of healthcare marketisation and privatisation miss an important point.

Altmetric Badge

Dimensions Badge

Item Type Article
URI https://centaur.reading.ac.uk/id/eprint/120039
Identification Number/DOI 10.1111/rati.70003
Refereed Yes
Divisions Arts, Humanities and Social Science > School of Humanities > Philosophy
Publisher Wiley
Download/View statistics View download statistics for this item

Downloads

Downloads per month over past year

University Staff: Request a correction | Centaur Editors: Update this record